Jesse J. Geiger is the President of Medpace Holdings Inc., a global clinical research organization (CRO) that provides comprehensive drug development and clinical trial services to pharmaceutical, biotechnology, and medical device companies. With a strong background in medicine and business, Geiger has been instrumental in guiding Medpace's growth and success since joining the company. Prior to his current role as President, Geiger served as the Executive Vice President of Medpace, where he played a key role in overseeing the company's operations and strategic initiatives. He has been with Medpace since its inception in 1992, contributing to the company's development from a startup to a leading CRO with a global presence. Geiger's medical expertise, coupled with his business acumen, has been crucial in driving Medpace's mission to accelerate the global development of safe and effective medical therapies. As President, Geiger is responsible for leading Medpace's overall strategy and operations, ensuring that the company continues to deliver high-quality services to its clients. Under his leadership, Medpace has expanded its service offerings, strengthened its global footprint, and maintained a strong commitment to innovation and excellence in clinical research. Geiger's vision and dedication have been vital to Medpace's success, positioning the company as a trusted partner in the drug development process and contributing to the advancement of healthcare worldwide.